Institutions profited after Achieve Life Sciences, Inc.'s (NASDAQ:ACHV) market cap rose US$48m last week but individual investors profited the most [Yahoo! Finance]
Achieve Life Sciences (NASDAQ:ACHV) is now covered by analysts at Citizens Jmp. They set a "market outperform" rating and a $19.00 price target on the stock.
Achieve Life Sciences (NASDAQ:ACHV) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Achieve Life Sciences (NASDAQ:ACHV) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..
Achieve Life Sciences (NASDAQ:ACHV) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.